Skip to main content
. 2006 Feb 14;12(6):940–944. doi: 10.3748/wjg.v12.i6.940

Figure 2.

Figure 2

(A1-A2) Course of plasma bile acids and urea concentrations before, during and after 2 d of Prometheus® therapy. Data are presented as median, quartiles, and minimum/maximum values. (B1-B2) Course of plasma TNF-α and IL-6 concentrations before, during and after 2 d of Prometheus® therapy. Data are presented as median, quartiles, and minimum/maximum values. (C1-C3) Course of antithrombin 3, factors II and V levels before, during and after 2 d of Prometheus® therapy. Data are presented as median, quartiles, and minimum/maximum values. (D1-D3) Course of plasma total protein, albumin, and fibrinogen before, during, and after 2 d of Prometheus® therapy. Data are presented as median, quartiles, and minimum/maximum values.